Bank Of America Corp Sorrento Therapeutics, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.74 - $1.83 $864,181 - $2.14 Million	1,167,813 Added 64.17%	2,987,772 $2.66 Million
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $650,760 - $1.24 Million	430,967 Added 31.03%	1,819,959 $2.86 Million
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $117,993 - $221,713	95,156 Added 7.35%	1,388,992 $2.79 Million
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $2.15 Million - $5.28 Million	1,076,786 Added 496.1%	1,293,836 $3.01 Million
Q4 2021 Feb 08, 2022	SELL	$4.65 - $7.23 $282,547 - $439,316	-60,763 Reduced 21.87%	217,050 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$7.41 - $10.99 $32,981 - $48,916	4,451 Added 1.63%	277,813 $2.12 Million
Q2 2021 Sep 13, 2021	BUY	$6.35 - $10.0 $1.74 Million - $2.73 Million	273,362 New	273,362 $2.65 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.